ArticleAging2023

Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer.

Shengxian Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.